Skip to content

Feasibility of Integrating MEditatioN inTO heaRt Disease (the MENTOR Study): A Phase II Randomized Controlled Trial.

Angela Rao, Robert Zecchin, Phillip J Newton, Scott A Read, Jane L Phillips, Michelle Digiacomo, Sungwon Chang, Alan Robert Denniss, Louise D Hickman

The Journal of cardiovascular nursing DOI: 10.1097/JCN.0000000000000997 via PubMed

Summary

AI-generated from the abstract

Among cardiac rehabilitation patients with mild depression or anxiety, adding a weekly 16-minute guided group meditation for six weeks, plus daily self-guided practice, is feasible and acceptable. In a randomized trial with 31 participants, 83% of the meditation group completed an average of 3.13 group sessions and 5.28 self-guided sessions. Patients, clinicians, and health managers found the meditation acceptable. Per-protocol analyses indicated that the meditation group attended more cardiac rehabilitation sessions (12 vs 9 sessions), suggesting meditation may improve adherence to exercise-based cardiac rehabilitation.

Study at a glance

Characteristics Mixed-methods feasibility randomized controlled trial Peer reviewed
Sample size 31
Population Patients with cardiovascular disease and at least mild depression and/or anxiety symptoms attending an Australian cardiac rehabilitation program
Intervention Meditation
Duration 6-week intervention, 12-week follow-up
Citations 2
Key finding Adding a 16-minute guided group meditation to standard cardiac rehabilitation is feasible and acceptable, and may improve patients' adherence to exercise-based cardiac rehabilitation sessions.

Abstract

Comorbid depression and/or anxiety symptoms occur in 25% of patients attending cardiac rehabilitation (CR) programs and are associated with poorer prognosis. There is a need to evaluate psychological interventions, including meditation, that have potential to improve psychological health in CR programs. The aim of this study was to determine the feasibility and acceptability of integrating a meditation intervention into an existing Australian CR program for the reduction of depression and anxiety symptoms. This was a mixed-methods feasibility randomized controlled trial. Thirty-one patients with CVD and, at a minimum, mild depression and/or anxiety symptoms were randomized to meditation and standard CR or to standard CR alone. A 16-minute guided group meditation was delivered face-to-face once a week for 6 weeks, with daily self-guided meditation practice between sessions. Feasibility outcomes included screening, recruitment, and retention. Semistructured interviews of patients' (n = 10) and health professionals' (n = 18) perspectives of intervention participation and delivery were undertaken to assess acceptability. Between-group differences in depression, anxiety, stress, self-efficacy for mindfulness, and health status at 6 and 12 weeks were also assessed. Meditation was considered feasible, with 83% (12/15) of the intervention group completing an average of 3.13 (SD, 2.56) out of 6 group meditation sessions and 5.28 (SD, 8.50) self-guided sessions. Meditation was considered acceptable by patients, clinicians, and health managers. Between-group differences in the number of CR sessions completed favored the intervention group in per-protocol analyses (intervention group vs control group, 12 vs 9 sessions; P = .014), which suggests that meditation may be useful to improve patients' adherence to exercise-based CR program.

Comments

No comments yet.

Log in to comment